Comparison between Alpa Laboratories IPO and Omaxe IPO.
Alpa Laboratories IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Omaxe IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Alpa Laboratories IPO is up to ₹61.07 Cr whereas the issue size of the Omaxe IPO is up to ₹605.94 Cr. The final issue price of Alpa Laboratories IPO is ₹68.00 per share and of Omaxe IPO is ₹310.00 per share.
| Alpa Laboratories IPO | Omaxe IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹62.00 per share | ₹265.00 per share |
| Issue Price (Upper) | ₹68.00 per share | ₹310.00 per share |
| Issue Price (Final) | ₹68.00 per share | ₹310.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | ₹0.00 per share |
| Market Lot Size | 100 shares | 20 shares |
| Fresh Issue Size | 89,80,600 shares | 1,95,46,520 shares |
| Fresh Issue Size (Amount) | up to ₹61.07 Cr | up to ₹605.94 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 89,80,600 shares | 1,95,46,520 shares |
| Issue Size Total (Amount) | up to ₹61.07 Cr | up to ₹605.94 Cr |
Alpa Laboratories IPO opens on Jul 12, 2007, while Omaxe IPO opens on Jul 17, 2007. The closing date of Alpa Laboratories IPO and Omaxe IPO is Jul 17, 2007, and Jul 20, 2007, respectively.
| Alpa Laboratories IPO | Omaxe IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Jul 12, 2007 | Jul 17, 2007 |
| Issue Close | Jul 17, 2007 | Jul 20, 2007 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Aug 06, 2007 | Aug 09, 2007 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Alpa Laboratories IPO P/E ratio is , as compared to Omaxe IPO P/E ratio of .
| Alpa Laboratories IPO | Omaxe IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 100 | 100 | ||||
| Promoter Shareholding (Post-Issue) | 55.94 | 88.8 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹146.61 Cr. | ₹5409.50 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW | 23.57 | 56.39 |
In the Alpa Laboratories IPO Retail Individual Investors (RII) are offered 32,37,500 shares while in Omaxe IPO retail investors are offered 32,37,500 shares. Qualified Institutional Buyers (QIB) are offered 46,25,000 shares in Alpa Laboratories IPO and 1,15,50,000 shares in Omaxe IPO.
| Alpa Laboratories IPO | Omaxe IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | ||
| QIB | 46,25,000 shares | 1,15,50,000 shares |
| NII | 13,87,500 shares | 19,25,000 shares |
| RII | 32,37,500 shares | 57,75,000 shares |
| Employee | 2,50,000 shares | 2,96,520 shares |
| Others | ||
| Total | 95,00,000 shares | 1,95,46,520 shares |
Alpa Laboratories IPO subscribed 1.11x in total, whereas Omaxe IPO subscribed 68.44x.
| Alpa Laboratories IPO | Omaxe IPO | |
|---|---|---|
| QIB (times) | 0.18x | 95.32x |
| NII (times) | 1.99x | 81.16x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 2.14x | 13.89x |
| Employee (times) | 0.01x | 1.14x |
| Other (times) | ||
| Total (times) | 1.11x | 68.44x |
